Delay in diagnosis of slipped capital femoral epiphysis has important implications with regard to slip severity and long-term hip outcomes. The aims of this review were to identify the incidence of delayed diagnosis of slipped capital femoral epiphysis in the hospital to which the authors are affiliated, and the causes for such delays. A retrospective review was conducted of all patients admitted to the Women's and Children's Hospital in Adelaide between January 1997 and October 2004 with a diagnosis of slipped capital femoral epiphysis. The inpatient and outpatient medical records for each patient were analysed to clarify the history of presentation and identify those patients with a delayed diagnosis. All radiographs were reviewed and the severity of the slip graded according to Southwick's classification. One hundred and two patients were included in this review, of which 20 had a delayed diagnosis and 25 a late presentation. Of the 20 (19.6%) patients who had a delayed diagnosis in this series, a minimum of 2 weeks elapsed between presentation to a health professional and diagnosis of slipped capital femoral epiphysis. Eight patients had seen their local doctor but the diagnosis was not made. The remaining 12 patients with delayed diagnosis had not seen a medical practitioner and had self-referred to a chiropractor or a physiotherapist. All of these patients underwent hip manipulation prior to diagnosis. There was a significant relationship between delay in diagnosis and an increased slip severity, when compared with both the remainder of this series and the late presentation group. Knee or distal thigh pain in slipped capital femoral epiphysis remains the commonest pitfall in diagnosis for local doctors, as well as mild slips being missed on radiograms by inexperienced surgeons or radiologists. An increasing presentation of adolescents with this disorder to allied health professionals for initial management warrants a broader education strategy than has been previously advocated. Slipped capital femoral epiphysis remains an enigmatic disorder; consequently delayed diagnosis of this condition is not likely to disappear. Despite this, the medical community must strive toward early diagnosis through continued education and vigilance.
There are numerous industry byproducts that have negative environmental impacts. Pond ash accumulated from coal power plants is one such byproduct that creates major environmental and social issues, especially with regard to decommissioning a coal power plant. Using pond ash in the block manufacturing process is a promising solution proposed by Nu-Rock. This research study evaluated the economic impact throughout the life cycle of Nu-Rock blocks. Nu-Rock block production use a technology called “Nu-creeting” in ash dams to prevent dust generation followed by the block manufacturing process using pond ash as a raw material. Nu-Rock technology can process approximately 250,000 tonnes of ash per annum and manufacture the equivalent of up to 330,000 tonnes volume of traditional building materials. This manufacturing process already generates jobs and pays tax and royalty fees to local governments, which is an added advantage. The total operating cost for 1 tonne of Nu-Rock blocks amounts to approximately AUD48, and the cost of a Nu-Rock block is AUD1.50–2.40, which is within the range of common bricks. Although there is a considerable initial cost to this process, it derives significant economic benefits in terms of manufacturing blocks using industrial byproducts, job creation and even tax revenue. Apart from these economic benefits, the Nu-Rock block manufacturing process generates environmental benefits through the reuse of pond ash from decommissioned coal power plants.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.